Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 07, 2021 16:30 ET | Source: OpGen, Inc.

OpGen Announces Partial Adjournment of Annual Meeting

Adjournment solely with respect to Proposal 2 (increase in authorized shares)Company and Board to Explore Alternative Options ROCKVILLE, Md., July 07, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc....
June 30, 2021 07:30 ET | Source: OpGen, Inc.

OpGen Announces Prospective Clinical Data from Unyvero LRT BAL and Acuitas AMR Gene Panel for Isolates Data Presented at World Microbe Forum

- Unyvero studies demonstrated potential for therapy adjustment in 42% to 53% of patients with results available 1 to 2 days faster - Acuitas AMR Gene Panel for Isolates (RUO) studies demonstrate...
June 28, 2021 07:30 ET | Source: OpGen, Inc.

OpGen Group Company Ares Genetics Presents R&D Pipeline Updates

Preliminary data demonstrates robust performance on nanopore sequencingAccuracy of 100% for pathogen identification and up to 97% for AMR markers and up to 100% on predicting AST ROCKVILLE, Md.,...
June 09, 2021 16:30 ET | Source: OpGen, Inc.

OpGen Announces Partial Adjournment of Annual Meeting for Proposal 2 with All Other Proposals Passed

ROCKVILLE, Md., June 09, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power of molecular diagnostics and informatics to...
June 09, 2021 07:30 ET | Source: OpGen, Inc.

OpGen Group Company Ares Genetics Presents at AWS and Twist Bioscience Webinars

ROCKVILLE, Md., June 09, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat...
June 07, 2021 07:30 ET | Source: OpGen, Inc.

OpGen Submits Updated 510(k) Summary to FDA and Successfully Completes Move to New Headquarters in Maryland

ROCKVILLE, Md., June 07, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat...
May 13, 2021 07:30 ET | Source: OpGen, Inc.

OpGen Reports First Quarter 2021 Financial Results and Provides Business Update

Total Revenue for Q1 2021 was approximately $0.8 millionBalance sheet strengthened significantly with an additional $34.7 million cash raised in Q1 2021 Conference call to be held at 8:30 a.m....
April 29, 2021 07:30 ET | Source: OpGen, Inc.

OpGen to Provide Business Update and Financial Results for the First Quarter 2021 on May 13th at 8:30 a.m. Eastern Time

GAITHERSBURG, Md., April 29, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its first...
April 19, 2021 07:30 ET | Source: OpGen, Inc.

OpGen Extends and Expands Partnership with New York State Department of Health to Detect Antimicrobial-Resistant Infections

Collaboration with NYS Department of Health’s Wadsworth Center continues for extended six-month term until September 30, 2021 Project utilizes OpGen’s Acuitas® AMR Gene Panel and Acuitas Lighthouse®...
April 12, 2021 07:30 ET | Source: OpGen, Inc.

OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in COVID-19 Patients

Experts presented the results of their Unyvero studies and demonstrated: Distinguishing those COVID-19 ICU patients with bacterial superinfection early and accurately is crucial for patient...